Publications

  1. TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling. Amson R, Senff-Ribeiro A, Karafin T, Lespagnol A, Honoré J, Baylot V, Banroques J, Tanner NK, Chamond N, Dimitrov JD, Hoebeke J, Droin NM, Job B, Piard J, Bommer UA, Choi KW, Abdelfatah S, Efferth T, Telerman SB, Geyer FC, Reis-Filho J, Telerman A. EMBO Rep. 2024 Apr;25(4):1962-1986.

  2. Topoisomerase II is regulated by translationally controlled tumor protein for cell survival during organ growth in Drosophila. Dae-Wook Yang, Jung-Wan Mok, Stephanie B. Telerman, Robert Amson, Adam Telerman and Kwang-Wook Choi. Cell Death Dis. 2021, 12:811

  3. Dysregulation of TCTP in Biological Processes and Diseases. Bommer UA, Telerman A. Cells. 2020 Jul 7;9(7):E1632.

  4. Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment. Amson R, Auclair C, André F, Karp J, Telerman A. Results Probl Cell Differ. 2017;64:283-290.

  5. Introduction: How We Encountered TCTP and Our Purpose in Studying It. Telerman A, Amson R. Results Probl Cell Differ. 2017;64:1

  6. TCTP/tpt1—Remodeling Signaling from Stem Cell to Disease; Telerman, A.E., Amson, R.E., Eds.; Springer International Publishing AG, Cham, Switzerland: 2017; Volume 64, pp. 1–309. 

  7. TCTP as a therapeutic target in melanoma treatment. Boia-Ferreira M, Basílio AB, Hamasaki AE, Matsubara FH, Appel MH, Da Costa CRV, Amson R, Telerman A, Chaim OM, Veiga SS, Senff-Ribeiro A. Br J Cancer. 2017 Aug 22;117(5):656-665.

  8. Acetylation of translationally controlled tumor protein promotes its degradation through chaperone-mediated autophagy. Bonhoure A, Vallentin A, Martin M, Senff-Ribeiro A, Amson R, Telerman A, Vidal M. Eur J Cell Biol. 2017 Mar; 96(2):83-98.

  9. TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL. Stéphanie Thébault ,Morgane Agez, Xiaoke Chi, Johann Stojko, Vincent Cura, Stéphanie B. Telerman, Laurent Maillet, Fabien Gautier, Isabelle Billas-Massobrio, Catherine Birck, Nathalie Troffer-Charlier, Teele Karafin, Joane Honoré,
Andrea Sen -Ribeiro, Sylvie Montessuit, Christopher M. Johnson, Philippe Juin, Sarah Cianférani, Jean-Claude Martinou, David W. Andrews, Robert Amson, Adam Telerman, Jean Cavarelli. Sci. Rep. 2016, 6, 19725.                                                                                                                                                 

  10. Abnormal erythroid maturation leads to microcytic anemia in the TSAP6/Steap3 null mouse model. Blanc L, Papoin J, Debnath G, Vidal M, Amson R, Telerman A, An X, Mohandas N. Am J Hematol. 2015 Mar. 90(3): 235-41.

  11. Lessons from tumor reversion for cancer treatment. Amson R, Karp JE and Telerman A. Current Opinion in Oncology 2013 Jan; 25(1): 59-65.

  12. TPT1/TCTP-regulated pathways in phenotypic reprogramming. Amson R, Pece S, Marine JC, Di Fiore PP and Telerman A. Trends in Cell Biology 2013 January.

  13. Reciprocal repression between P53 and TCTP. Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, Chaloin O, Hoebeke J, Marine JC, Di Fiore PP, Telerman A. Nature Med. 2012 Jan18 (1): 91-100

  14. A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S, Amson R, Telerman A, Nielsen P, Kohne E, Balser C, Heimpel H. Blood 2011 Dec 15; 118 (25): 6660-6.

  15. Could TCTP contribute to Armin Braun's paradigm of tumor reversion in plants? Amson R, Kubiak JZ, Van Montagu M, Telerman A. Cell Cycle 2011 Jan 1;10 (1):1.

  16. Tumor reversion holds promise. Telerman A, Amson R, Hendrix MJ. Oncotarget 2010 Aug; 1(4): 233-4

  17. Obituary: Jean Dausset. Telerman A, Amson R, Demant P, Marrack P. Immunity 2009 Aug 21; 31 (2): 171-3

  18. The molecular programme of tumour reversion: the steps beyond malignant transformation. Telerman A, Amson R. Nature Reviews Cancer 2009 Mar.9 (3): 206-16.

  19. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, Vidal M, Amson R, Telerman A. Cell Death Differ. 2008 Nov;15 (11):1723-33

  20. TCTP protects from apoptotic cell death by antagonizing bax function. Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine JC, Martinou JC, Cavarelli J, Moras D, Amson R, Telerman A. Cell Death Differ. 2008 Aug;15 (8):1211-20

  21. Translationally controlled tumor protein is a target of tumor reversion. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Geant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J, Moras D, Amson R, Telerman A. Proc Natl Acad Sci USA 2004; 101: 15364-15369

  22. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B, Amson R, Telerman A. J Biol Chem. 2004; 279: 46104-46112

  23. Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Geant A, Buchwalter G, Tuynder M, Susini L, Lassalle JM, Wasylyk C, Wasylyk B, Oren M, Amson R, Telerman A. Proc Natl Acad Sci USA 2004; 101: 3510-3515

  24. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation  elongation factor eEF1A. Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N, Allanic D, Tufino R, Argentini M, Moras D, Fiucci G, Goud B, Mirande M, Amson R, Telerman A. Proc Natl Acad Sci USA 2003; 100: 13892-13897

  25. Genomic organization and expression of mouse Tpt1 gene. Fiucci G, Lespagnol A, Stumptner-Cuvelette P, Beaucourt S, Duflaut D, Susini L, Amson R, Telerman A. Genomics 2003; 1 (6): 570-578

  26. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel De Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L, Morchoisne S, Crible V, Lespagnol A, Dausset J, Oren M, Amson R, Telerman A. Proc. Natl. Acad. Sci. USA 2003; 100: 2284-2289

  27. Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, Telerman A. Proc. Natl. Acad. Sci. USA 2002; 99: 14976-14981

  28. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Alves da Costa C, Paitel E, Mattson MP, Amson R, Telerman A, Anciolo K, Checler F. Proc. Natl. Acad. Sci. USA 2002; 99: 4043-4048

  29. Siah-1 binds and regulates the function of Numb. Susini L, Passer BJ, Amzallag-Elbaz N, Juven-Gershon T, Prieur S, Privat N, Tuynder M, Gendron MC, Israel A, Amson R, Oren M, Telerman A. Proc. Natl. Acad. Sci. USA 2001; 98: 15067-15072

  30. Behavioural Alterations Associated with Apoptosis and Down-regulation of Presenilin 1 in the Brains of p53-Deficient Mice. Amson R, Lassalle JM, Halley H, Prieur S, Lethrosne F, Roperch JP, Israeli D, Gendron MC, Duyckaerts C, Checler F, Dausset J, Cohen D, Oren M, Telerman A. Proc. Natl. Acad. Sci. USA 2000; 97,  5346-5350

  31. SIAH-1 inhibits cell growth by altering the mitotic process. Bruzzoni-Giovanelli H, Faille A, Linares-Cruz G, Nemani M, Le Deist F, Germani A, Chassoux D, Millot G, Roperch JP, Amson R, Telerman A, Calvo F. Oncogene 1999; 18, 7101-7109

  32. Inhibition of Presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Roperch JP, Alvaro V, Prieur S, Tuynder M, Nemani M, Lethrosne F, Piouffre L, Gendron MC, Israeli D, Dausset J, Oren M, Amson R, Telerman A. Nature Med. 1998; 4, 835-838

  33. SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding and trafficking: identification of common effectors with p53 and p21Waf1. Roperch JP, Lethrone F, Prieur S, Piouffre L, Israeli D, Tuynder M, Nemani M, Pasturaud P, Gendron MC, Dausset J, Oren M, Amson RB, Telerman A. Proc. Natl. Acad. Sci. USA 1999; 96, 8070-8073

  34. p21 WAF1 reorganizes the nucleus in tumor suppression. Linares-Cruz G, Bruzzoni-Giovanelli H, Alvaro V, Roperch JP, Tuynder M, Schoevaert D, Nemani M, Prieur S, Lethrosne F, Piouffre L, Reclar V, Faille A, Chassoux D, Dausset J, Amson RB, Calvo F, Telerman A. Proc. Natl. Acad. Sci. USA 1998; 95, 1131-1135

  35. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A, Oren M. EMBO Journal 1997; 16, 4384-4392

  36. Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Nemani M, Linares-Cruz G, Bruzzoni-Giovanelli H, Roperch JP, Tuynder M, Bougueleret L, Cherif D, Medhioub M, Pasturaud P, Alvaro V, der Sarkissan H, Cazes L, Le Paslier D, Le Gall I, Israeli D, Dausset J, Sigaux F, Chumakov I, Oren M, Calvo F, Amson RB, Cohen D, Telerman A. Proc. Natl. Acad. Sci. USA 1996; 93, 9039-9042

  37. Isolation of ten differentially expressed cDNAs in p53 induced apoptosis: Activation of the vertebrate homologue of the Drosophila seven in absentia gene. Amson RB, Nemani M, Roperch JP, Israeli D, Bougueleret L, Le Gall I, Medhioub M, Linares-Cruz G, Lethrosne F, Pasturaud P, Piouffre L, Prieur S, Susini L, Alvaro V, Millasseau P, Guidicelli C, Bui H, Massart C, Cazes L, Dufour F, Bruzzoni-Giovanelli H, Owadi H, Hennion C, Charpak G, Telerman A. Proc. Natl. Acad. Sci. USA 1996; 93, 3953-3957

  38. A model for tumor suppression using H-1 parvovirus. Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R. Proc. Natl. Acad. Sci. USA 1993; 90, 8702-8706

  39. Identification of the cellular protein encoded by the human Wilm's tumor (WT1) gene. Telerman A, Dodemont H, Degraef C, Galand P, Bauwens S, Van Oostveldt P, Amson R. Oncogene 1992; 7, 2545-2548

  40. The human protooncogene p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Amson R, Sigaux F, Przedborski S, Flandrin G, Givol D, Telerman A. Proc. Natl. Acad. Sci. USA 1989; 86, 8857-8861

  41. Identification of a 130 Kda bcr related gene product. Amson R, Marcelle C, Telerman A. Oncogene 1989; 4, 243-247

  42. Hybridoma-derived human suppressor factors: differential effects on mouse lymphocytes. Telerman A, Merluzzi VJ, Calvelli TA, Kunicka JE, Platsoucas CD. Hybridoma 1989; 8: 25-36

  43. Human suppressor factors constitutively produced by T-T cell hybridomas. Functional and biochemical characterization. Kunicka JE, Calvelli TA, Fox FE, Steinberg J, Telerman A, Platsoucas C. Hybridoma 1989; 8: 127-152

  44. Identification of the human pim-1 gene product as a 33-kilodalton cytoplasmatic protein with tyrosine kinase activity. Telerman A, Amson RB, Zakut-Houri R, Givol D. Molecular and Cellular Biology 1988; 8,1498-1503

  45. Lactoferrin and iron in alcoholics after ethanol withdrawal. Amson R, Telerman A, Przedborski S, Verbanck M, Robyn C. Medical Science Research 1988:16, 231-232

  46. cDNA sequence and Gene structure of the human pim oncogene. Telerman A, Amson R, Zakut-Houri R, Givol D. Gene 1987; 54,105-111

  47. Internalization of human T cell receptors. Telerman A, Amson RB, Romasco F, Wybran J, Galand P, Mosselmans R. European Journal of Immunology, 1987; 17,  991-997

  48. Management of myelodysplastic syndromas. Sztern B, De Saint-Georges A, Telerman A, Lustman F. American Journal of Medicine 1987; 82:187

  49. Internalization of the T3 differentiation antigen after binding with monoclonal OKT3 antibody. Telerman A, Mosselmans R, Amson R, Romasco F, Dupont E, Galand P, Wybran J. J. Biology Cell 1985; 53-27

  50. Chemical crosslinking of the T3 antigen with other cell surface molecules. Telerman A, Sakar F, Kunicka J, Gupta S, Platsoucas CD. Fed. Proc. USA 1985; 44: 789

  51. Gastrointestinal metastases from extraabdominal tumors. Telerman A, Gerard B, Van den Heule B, Bleiberg H. Endoscopy I985; 17: 13,99-101

  52. Lactoferrin: No evidence of its role in regulation of CSA production by human lymphocytes and monocytes. Stryckmans P, Delforge A, Amson RB, Prieels JP, Telerman A, Bieva C, Deschuyteneer M, Ronge-Collard E. Blood Cells 1984; 10: 369-395

  53. Galactosyltransferase/Sialyltransferase activity as an index of membrane glycosylation of lymphocyte subpopulations. Telerman A, Amson R, Monnom D, Di Virgilio S, Mertens N, Perraudin, JP, Prieels JP. Protides of the Biological Fluids 1984; 859-862. Ed. E. Peeters. Pergamon Press

  54. Sidéroblastose majeure corrigée par simple administration de folates. Sztern B, De Saint-Georges A, Telerman A, Lustman F. La Presse Médicale 1984;13:1789

  55. Heparin induced hyperkalemia. Heymans G, Telerman A, Deconinck I, Brauman H. Acta Clinica 1984; 39 :205-209

  56. Iatrogenic pulmonary oedema. Haber C, Telerman A. Rev. Med. 1984; 5: 273-277

  57. Comparison of the interaction of lactoferrin with hepatocytes,lymphocytes and monocytes. Amson R, Telerman A, Deschuyteneer M, Mosselmans R, Perraudin JP, Strijckmans, P, Prieels JP. Protides of the Biological Fluids 1983; 137-140. Ed. E. Peeters. Pergamon Press.

  58. Chronic Aneosinocytosis. Telerman A, Amson RB, Delforge A, Collard E, Stryckmans PA. American Journal of Hematology 1982; 12:187-197

Selected conferences and abstracts (* with presentation)

  1. Adam Telerman and Robert Amson. American Association for Cancer Research (AACR) Annual Meeting, Philadelphia, April 2015.

  2. Adam Telerman and Robert Amson. Mechanisms & Models of Cancer Cold Spring Harbor, August 2014.

  3. Robert Amson, Andrea Senff Ribeiro, Salvatore Pece, Pier Paolo Di Fiore Judith E Karp, Jean-Christophe Marine and Adam Telerman. Tumor reversion: from bench to potential clinical applications using Sertraline and Thioridazine. American Association for Cancer Research (AACR) Annual Meeting, Washington, April 2013*

  4. Robert Amson, Salvatore Pece, Alexandra Lespagnol, Rajesh Vyas, Giovanni Mazzarol, Daniela Tosoni, Ivan Colaluca, Giuseppe Viale, Sylvie Rodrigues-Ferreira, Jessika Wynendaele, Olivier Chaloin, Johan Hoebeke, Jean Christophe Marine, Pier Paolo Di Fiore, and Adam Telerman. TCTP promotes MDM2-mediated ubiquitination and degradation of p53. Sixth International Mdm2 Workshop, New York October 2012 *.

  5. Robert Amson, Salvatore Pece, Alexandra Lespagnol, Rajesh Vyas, Giovanni Mazzarol, Daniela Tosoni, Ivan Colaluca, Giuseppe Viale, Sylvie Rodrigues-Ferreira, Jessika Wynendaele, Olivier Chaloin, Johan Hoebeke, Jean-Christophe Marine, Pier Paolo Di Fiore and Adam Telerman. Relevance of the repressive feedback loop between p53 and TCTP in stemness and cancer treatment. Mechanisms and Models of Cancer 2011. Salk Institute for Biological Studies, La Jolla, CA, August 2011*.

  6. Adam Telerman and Robert Amson. The biology of Cancer: microenvironment, metastasis & therapeutics. Cold Spring Harbor, April 2011.

  7. Robert Amson, Adam Telerman and Christian Auclair. Tumor reversion program. Annual meeting of Conticanet (European Connective Tissue Network) Paris January 2011*.

  8. Robert Amson, Salvatore Pece, Alexandra Lespagnol, Giovanni Mazzarol, Sylvie Rodriguez-Ferreira, Daniela Tosoni, Ivan Colaluca, Jean-Christophe Marine, Olivier Chaloin, Johan Hoebeke, Pier Paolo Di Fiore and Adam Telerman. New molecular insights into a key role for TCTP in tumorigenesis and tumor reversion. Mechanisms and Models of Cancer. Cold Spring Harbor, August 2010*.

  9. Adam Telerman and Robert Amson. Mechanisms and Models of Cancer. Salk Institute for Biological Studies, La Jolla, CA, August 2009.

  10. Adam Telerman and Robert Amson. TSAP6/Steap3 regulates p53-dependent secretion of exosomes. Inhibition of the interaction between TSAP6 and TCTP promotes cell death. Mechanisms and Models of Cancer. Cold Spring Harbor, August 2008*.

  11. Adam Telerman and Robert Amson. PTEN meeting. Cold Spring Harbor, March 2008.

  12. Adam Telerman and Robert Amson. Cell Death conference. Cold Spring Harbor, September 2007.

  13. Adam Telerman and Robert Amson. Mechanisms and Models of Cancer. Salk Institute for Biological Studies, La Jolla, CA, August 2007.

  14. Adam Telerman and Robert Amson. Mechanisms and Models of Cancer. Cold Spring Harbor, August 2006.

  15. Adam Telerman and Robert Amson. 3rd International Mdm2 Workshop. Konstanz, September 2005.

  16. Adam Telerman and Robert Amson. Tumor reversion as an alternative approach in cancer research: biological models, molecular pathways and identification of target proteins for potential cancer therapies. LXX Cold Spring Harbor Symposium on quantitative Biology. Molecular Approaches To Controlling Cancer. Cold Spring Harbor, June 2005*.

  17. B. Passer, C. Cans, V. Nancy-Portebois, V. Crible, R. Amson, and A. Telerman. TCTP regulates the activity of the microtubule destabilizing protein. Cancer Genetics and Tumor Suppressor Genes. Cold Spring Harbor, August 2004*.

  18. B. Passer, N. Amzallag, D. Allanic, E. Segura, C. Théry, B. Gould, R. Amson and A. Telerman. TSAP6 facilitates the secretion of TCTP/HRF via a non-classical pathway. Cancer Genetics and Tumor Suppressor Genes. Cold Spring Harbor, August 2004*.

  19. B. Passer, R. Amson and A. Telerman. Conference on Programmed cell death. Cold Spring Harbor, September 2003.

  20. M. Tyunder, L. Susini, S. Prieur, S. Besse, N. Privat, R. Amson and A. Telerman. Biological models and genes of tumor reversion: cellular reprogramming through inhibition of TPT1/TCTP. Cancer Genetics and Tumor Suppressor Genes. Cold Spring Harbor, August 2002*.

  21. M. Tuynder, L. Susini, J. Richardson, L. Goodman, B. Bowen, A. Géant, M. Oren, R. Amson and A. Telerman. Characterization of biological models and molecular pathways of tumor reversion: cross-talk with programmed cell death. Conference on Programmed cell death. Cold Spring Harbor, September 2001*.

  22. L. Susini, B. Passer, N. Amzallag-Elbaz, T. Juven-Gershon, S. Prieur, N. Privat, M. Tuynder, M. Oren, R. Amson and A.Telerman. SIAH binds and regulates the function of Numb. Conference on Programmed cell death. Cold Spring Harbor, September 2001*.

  23. B. Passer, S. Prieur, A. Roborel de Climens, V. Nancy-Portebois, N. Privat, N. Amzallag-Elbaz, R. Amson and A.Telerman. The p53-inducible TSAP6 gene product interacts with Nix and the Myt1 kinase : Implications of  apoptosis and the cell control. Conference on Programmed cell death. Cold Spring Harbor, September 2001*.

  24. M. Tuynder, L. Susini, J. Richardson, L. Goodman, A. Géant, F. Dufour, E. Mas, S. Zyto, J. Tolédano, M. Oren, S. Brenner, R. Amson and A. Telerman. Characterisation of biological models and molecular pathways of tumor reversion. Annual Meeting on Oncogenes, Frederick, Maryland, USA, June 2001*.

  25. M. Tuynder, F. Lethrosne, S. Prieur, J.P. Roperch, L. Susini, M. Oren, and A. Telerman. Uncovering tumor suppression pathways by investigationg tumor reversion. Conference on cancer genetics and tumor suppressor genes. Cold Spring Harbor, August 2000*

  26. J.P. Roperch, F. Lethrosne, S. Prieur, D. Israeli, L. Piouffre, M. Nemani, P. Pasturaud, J. Dausset, M. Oren, R. Amson, and A. Telerman. Siah-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding and trafficking: identification of common effectors with p53 and p21waf1. Fifteenth annual meeting on oncogenes and tumor suppressors, June 1999*.

  27. R. Amson, M. Lassalle, H. Halley, C.. Duyckaerts, J.P. Roperch, S. Prieur, D. Israeli, F. Lethrosne, L. Piouffre, F. Checler, J. Dausset, M. Oren, and A. Telerman. Apoptosis in the brains of p53 knock-out mice: a presenilin1-dependent mechanism with memory and behavioural alterations. Conference on programmed cell death. Cold Spring Harbor, October 1999*.

  28. R. Amson, J.P. Roperch, V. Alvaro, M. Nemani, S. Prieur, M. Tuynder, G. Linares-Cruz, H. Bruzzoni-Giovanelli, F. Lethrosne, L. Piouffre, D. Israeli, F. Calvo, M. Oren and A. Telerman. The humsiah 1 and presenilin 1 genes are active components of a complex network regulating tumor suppression and apoptosis. Conference on cancer genetics and tumor suppressor genes. Cold Spring Harbor, August 1998*.

  29. M. Nemani, J.P. Roperch, S. Prieur, M. Tuynder, F. Lethrosne, L. Piouffre, V. Alvaro, F. Calvo, D. Israeli, M. Oren, R. Amson, and A. Telerman. Presenilin 1 at the crossroad of Alzheimer’s disease and cancer. Conference on programmed cell death. Cold Spring Harbor, September 1997*.

  30. G. Linares-Cruz, H. Bruzzoni-Giovanelli, V. Alvaro, J.P. Roperch, M. Tuynder, D. Schoevaert, M. Nemani, M. Medhioub, D. Chassoux, J. Dausset, R. Amson, F. Calvo and A. Telerman. P21 waf1 reorganizes the nucleus in tumor suppression. Cancer genetics and tumor suppressor genes conference, June 1997*.

  31. A. Telerman, M. Nemani, J.P. Roperch, G. Lineares Cruz, H. Bruzzoni Giovanelli, V. Alvaro, D. Israeli, M. Medhioub, L. Bougueleret, D. Cherif, D. Le Paslier, I. Le Gall, J. Dausset, F. Calvo, M. Oren, D. Cohen and R. Amson. The human homologue of the Drosophila seven in absentia gene in apoptosis and tumor suppression. Twelfth Annual Meeting on Oncogenes, Frederick, Maryland, USA, June 1996*.

  32. Adam Telerman and Robert Amson. The cell cycle. Keystone Symposium, Taos, New Mexico, January 1996.

  33. Adam Telerman and Robert Amson. Conference on Programmed cell death. Cold Spring Harbor, September 1995.

  34. A. Telerman, M. Tuynder, T. Dupressoir, B. Robaye, F. Sigaux, E. Shaulian, M. Oren, J. Rommelaere and R. Amson. A model for tumor suppression using H-1 parvovirus. 5th Parvovirus Workshop, Crystal River, Florida, USA, November 1993*.

  35. A. Telerman, M. Tuynder, T. Dupressoir, B. Robaye, F. Sigaux, E. Shaulian, M. Oren, J. Rommelaere and R. Amson. Selection of a suppressed phenotype in a human leukemia by means of H-1 parvovirus. Ninth Annual Meeting on Oncogenes, Frederick, USA, June 1993*.

  36. R. Amson, F. Sigaux, S. Przedborski, A. Telerman Expression of the p33pim during human fetal hematopoiesis and in leukemias. EMBL Conference, Oncogenes and Growth Control, Heidelberg, April 1990*.

  37. A. Telerman, F. Sigaux, S. Przedborski, J-P. Brion, P. Van Oostveldt, G. Flandrin, D. Givol, R. Amson Expression of the p33pim during human fetal hematopoiesis and in leukemias. Fifth Annual Meeting on Oncogenes, Frederick, MD, June 1989*.

  38. A. Telerman and R. Amson. Cold Spring Harbor Symposium on Quantitative Biology. Molecular Biology of Signal Transduction. Cold Spring Harbor, June 1988.

  39. A. Telerman, R. Amson, R. Zakut-Houri, D. Givol. Characterization of the human pim-1 oncogene and its 33 Kd tyrosine kinase protein product. Fourth Annual Meeting on Oncogenes. Frederick, June I988, National Cancer Inst. *.

  40. R. Zakut Houri, S. Hazum, D. Givol, A. Telerman. cDNA sequence and gene analysis of the human pim oncogene.

    EMBL Conference: Oncogene and Growth Control. Heidelberg I987 *.

  41. R. Amson, C. Marcel, N. Taylor, B. Lifshitz, E. Feinstein, A. Telerman, E. Shtivelman, R.P. Gale, E. Canaani. Bcr gene transcripts. Oncogene Meeting, National Cancer Inst. Maryland (1987)*.

  42. R. Amson, C. Marcel, N. Taylor, A. Telerman, E. Canaani. Identification of a bcr gene product. EMBL Conference: Oncogene and Growth Control. Heidelberg 1987*.

  43. A. Telerman , R. Mosselmans, R. Amson, F. Romasco, E. Dupont, P. Galand, J. Wybran. Internalization of the T3 differentiation antigen after binding with monoclonal OKT3 antibody. Proceedings of the 7th  European Immunology Meeting (1985)*.

  44. A. Telerman, J. Squires, F. Sarkar, S. Gupta, C.D. Platsoucas. Chemical crosslinking of the T3 antigen with the beta chain of the T cell  receptor. Proceedings of the 7th European Immunology Meeting (1985) *.

  45. A. Telerman, F. Sarkar, J. Kunicka, S. Gupta, C.D. Platsoucas. Crosslinking of the T3 antigen with other cell surface molecules. American Society of  Experimental Biology (1985).

  46. A. Telerman, S. Kempin, M. Isaacs, F. Chae, S. Ellis, B. Clarkson. Effect of renal failure upon treatment of Acute Nonlymphocytic Leukemia. American Society of Hematology, 26th Meeting, Miami (1984).

  47. A. Telerman R. Amson, M. Deschuyteneer, R. Mosselmans, J-P Perraudin, P. Strijckmans, J-P Prieels. Galactosyltransferase/Sialyltransferase activity as an index of membrane glycosylation of lymphocyte subpopulations. Proceedings of the Colloquium on the Protides of the Biological Fluids. Brussels, 1984*.

  48. R. Amson, A. Telerman, M. Deschuyteneer, R. Mosselmans, J-P Perraudin, P. Strijckmans, J-P Prieels. Comparison of the interaction of lactoferrin with hepatocytes, lymphocytes and monocytes. Proceedings of the Colloquium on the Protides of the Biological Fluids. Brussels 1983*.

  49. A. Telerman, H. Bleiberg, B. Van den Heule, A. Gérard. Metastases to the gastrointestinal wall. Meeting Gastroenterology. Brussels 1981*.

  50. A. Telerman, R. Amson, A. Delforge, E. Collard, P. Strijckmans. Chronic aneosinocytosis. Proceedings of the International Meeting of Hematology. Montréal 1980*.